Financial insights of SDGR

MyFinsight

For the quarter ending 2025-09-30, SDGR made $54,324K in revenue. -$32,795K in net income. Net profit margin of -60.37%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Total revenues	54,324	54,759	59,551	35,290
Software Products And Services	11,111	13,029	-	-
Drug Discovery	15,174	15,572	-	-
Total cost of revenues	26,285	28,601	28,427	17,562
Gross profit	28,039	26,158	31,124	17,728
Research and development	42,757	43,138	45,844	50,977
Sales and marketing	9,524	10,734	10,367	10,349
General and administrative	21,705	25,189	25,802	24,824
Total operating expenses	73,986	79,061	82,013	86,150
Loss from operations	-45,947	-52,903	-50,889	-68,422
Gain (loss) on equity investments	0	0	-	-
Change in fair value of equity investments	9,691	4,579	-13,095	-
Other income	3,623	5,438	4,204	4,737
Change in fair value	-	-	-	25,459
Total other income	13,314	10,017	-8,891	30,196
Loss before income taxes	-32,633	-42,886	-59,780	-38,226
Income tax expense (benefit)	162	287	28	-90
Net loss	-32,795	-43,173	-59,808	-38,136

Net loss per share of common and limited common stockholders, basic (in usd per share)	-0.45	-0.59	-0.82	-0.52
Net loss per share of common and limited common stockholders, diluted (in usd per share)	-0.45	-0.59	-0.82	-0.52
Weighted average shares used to compute net loss per share of common and limited common stockholders, basic (in shares)	73,613,090	73,427,635	73,057,916	72,813,006
Weighted average shares used to compute net loss per share of common and limited common stockholders, diluted (in shares)	73,613,090	73,427,635	73,057,916	72,813,006